Altium Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-79,000
Closed -$5.83M 133
2022
Q1
$5.83M Buy
79,000
+20,000
+34% +$1.39M 1.95% 12
2021
Q4
$4.26M Buy
59,000
+20,500
+53% +$1.49M 1.17% 34
2021
Q3
$2.95M Sell
38,500
-32,333
-46% -$2.6M 0.77% 56
2021
Q2
$5.49M Buy
70,833
+21,971
+45% +$1.56M 1.27% 23
2021
Q1
$3.01M Buy
48,862
+17,350
+55% +$1.1M 0.84% 49
2020
Q4
$2.06M Buy
+31,512
New +$1.81M 0.77% 58

Other funds holding GMED

Altium Capital Management's GMED Position: Q2 2022 in Review

Altium Capital Management sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 79,000 shares — an estimated $5.83M sold.

Altium Capital Management first reported a position in GMED in Q4 2020 and held it in 6 quarters. The position peaked at $5.83M in Q1 2022. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

  • Altium Capital Management reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
  • Altium Capital Management sold 79,000 Globus Medical shares in Q2 2022, an estimated $5.83M.
  • Altium Capital Management first reported a position in Globus Medical in Q4 2020 and held it in 6 quarters.
  • Altium Capital Management's Globus Medical position peaked at $5.83M in Q1 2022.
  • 364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on Altium Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.